Qlucore opens first company outside Sweden in the USA

As a world leader in the development of bioinformatics software, Qlucore’s customer base now spans
more than 20 countries. In recognition of the role the US market has to play in this expansion, Qlucore
Inc. has been established in the States, the first Qlucore company to be established outside of
Sweden. Carl-Johan Ivarsson, President of Qlucore, is the CEO of Qlucore Inc.

“The USA is an important and fast-growing market for us,” commented Carl-Johan Ivarsson,
CEO Qlucore Inc. “The new office and the formation of Qlucore Inc. will strengthen our position
in the States, allow us to capitalize on the strength of the biotech industry, and enable us to
offer an enhanced level of service to our expanding American client base.” Qlucore Inc is
headquartered at 570 Lexington Avenue, New York.

The biotechnology industry in the States is home to more than 1,300 firms involved in the industry*.
There are more than 5.5 million scientists, engineers and technicians; 1.3 million people directly
involved in biosciences; and another 5.8 million workers in related industry sectors. With the world’s
largest scientific research base and longstanding government support for biomedical and other
biotechnology research and development, the United States maintains a competitive environment
for the development and commercialization of biotechnology. Against this background, Qlucore’s
business in the USA has increased by 100% over the past twelve months, with a number of new
contracts won involving Qlucore Omics Explorer.

This visualization-based software is a program which allows users, in particular researchers, to be up and running, performing data analysis, and studying their own data looking for patterns and structures, in a matter of hours. They do not need to be statistics or computer experts. This reduces project lead times considerably and lets scientists spend more time on testing theories and alternative hypothesis.